Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)

被引:0
|
作者
Sateria R. Venable
Ayman Al-Hendy
机构
[1] Fibroid Foundation,Department of Obstetrics and Gynecology
[2] University of Chicago,undefined
来源
Advances in Therapy | 2023年 / 40卷
关键词
Uterine fibroids; Heavy menstrual bleeding; Relugolix combination therapy; Patient perspective; Physician perspective;
D O I
暂无
中图分类号
学科分类号
摘要
Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article.
引用
收藏
页码:4127 / 4133
页数:6
相关论文
共 50 条
  • [31] Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas
    Al-Hendy, Ayman
    Lukes, Andrea S.
    Poindexter, Alfred N.
    Venturella, Roberta
    Villarroel, Claudio
    McKain, Laura
    Li, Yulan
    Wagman, Rachel B.
    Stewart, Elizabeth A.
    OBSTETRICS AND GYNECOLOGY, 2022, 140 (06): : 920 - 930
  • [32] Medical therapy for uterine leiomyomas
    Ignatov, A.
    Lattrich, C.
    Ortmann, O.
    GYNAKOLOGE, 2014, 47 (01): : 9 - 12
  • [33] Relugolix combination therapy reduced patient-reported distress from bleeding and pelvic symptoms and improved daily activities in patients with uterine fibroids in the LIBERTY program
    Stewart, E.
    Al-Hendy, A.
    Venturella, R.
    Poindexter, A., III
    Villarroels, C.
    Li, Y.
    Wagman, R. B.
    Hunsche, E.
    Lukes, A.
    HUMAN REPRODUCTION, 2020, 35 : 11 - 12
  • [34] Contemporary management of uterine fibroids: focus on emerging medical treatments
    Singh, Sukhbir Sony
    Belland, Liane
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 1 - 12
  • [35] Relugolix Combination Therapy Improves Uterine Fibroid Symptoms Independent of Fibroid Location
    Venturella, Roberta
    Lukes, Andrea S.
    Stewart, Elizabeth A.
    Proehl, Sarah
    Zhao, Xin
    Al-Hendy, Ayman
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 23S - 23S
  • [36] Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials
    Venturella, Roberta
    Rechberger, Tomasz
    Zatik, Janos
    Wagman, Rachel B.
    Zhu, Emily
    Rakov, Viatcheslav G.
    Petraglia, Felice
    GYNECOLOGICAL ENDOCRINOLOGY, 2023, 39 (01)
  • [37] CURRENT THERAPY - THE PERSPECTIVES OF PHYSICIAN AND PATIENT
    DAVIDSON, EAF
    FLUCONAZOLE AND ITS ROLE IN VAGINAL CANDIDIASIS, 1989, 160 : 7 - 10
  • [38] Migraine responds better to a combination of medical therapy and trigger point management than routine medical therapy alone
    Ghanbari, Ali
    Askarzadeh, Saghar
    Petramfar, Peyman
    Mohamadi, Marzieh
    NEUROREHABILITATION, 2015, 37 (01) : 157 - 163
  • [39] Medical therapy and new approaches to management of urolithiasis
    Pak, CYC
    Resnick, MI
    UROLOGIC CLINICS OF NORTH AMERICA, 2000, 27 (02) : 243 - +